The present invention relates to formylated xanthocillin analogues for use in the treatment of neurodegenerative diseases, to some of said analogues, as well as to methods for obtaining them and pharmaceutical composition comprising them. The invention also relates to a microorganism strain of the Penicillium chrysogenum species from which said analogues can be obtained.